Aspiration Risk Factors, Microbiology, and Empiric Antibiotics for Patients Hospitalized With Community-Acquired Pneumonia
نویسندگان
چکیده
Background Aspiration community-acquired pneumonia (ACAP) and (CAP) in patients with aspiration risk factors (AspRFs) are infections associated anaerobes, but limited evidence suggests their pathogenic role. Research Question What the factors, microbiology patterns, empiric anti-anaerobic use hospitalized CAP? Study Design Methods This is a secondary analysis of GLIMP, an international, multicenter, point-prevalence study adults CAP. Patients were stratified into three groups: (1) ACAP, (2) CAP/AspRF+ (CAP AspRF), (3) CAP/AspRF- without AspRF). Data on demographics, comorbidities, microbiological results, antibiotics analyzed all groups. further severe nonsevere CAP Results We enrolled 2,606 CAP, which 193 (7.4%) had ACAP. Risk independently ACAP male, bedridden, underweight, nursing home resident, having history stroke, dementia, mental illness, enteral tube feeding. Among non-ACAP patients, 1,709 (70.8%) 704 (29.2%) CAP/AspRF-. Microbiology patterns including anaerobes similar between CAP/AspRF-, (0.0% vs 1.03% 1.64%). higher rates total gram-negative bacteria (64.3% 44.3% 33.3%, P = .021) lower gram-positive (7.1% 38.1% 50.0%, < .001) when compared respectively. Most (>50% groups) independent AspRFs or received specific broad-spectrum coverage antibiotics. Interpretation Hospitalized anaerobic flora factors. Gram-negative more prevalent Despite groups, large proportion antibiotic coverage.
منابع مشابه
Comparative effectiveness of empiric antibiotics for community-acquired pneumonia.
BACKGROUND AND OBJECTIVE Narrow-spectrum antibiotics are recommended as the first-line agent for children hospitalized with community-acquired pneumonia (CAP). There is little scientific evidence to support that this consensus-based recommendation is as effective as the more commonly used broad-spectrum antibiotics. The objective was to compare the effectiveness of empiric treatment with narrow...
متن کاملCefepime versus Ceftriaxone for Empiric Treatment of Hospitalized Patients with Community-Acquired Pneumonia
Effective empiric treatment of pneumonia requires antibiotic coverage against gram-negative and grampositive pathogens, including drug-resistant isolates. We compared the safety and efficacy of intravenous (i.v.) cefepime (2 g administered every 12 h) to those of i.v. ceftriaxone (1 g administered every 12 h) for the empiric treatment of hospitalized patients with community-acquired pneumonia. ...
متن کاملCauses and risk factors for rehospitalization of patients hospitalized with community-acquired pneumonia.
BACKGROUND Rehospitalization after inpatient treatment of community-acquired pneumonia occurs in one-tenth of all hospitalizations, but the clinical circumstances surrounding readmission to the hospital have not been well studied. The objective of this study was to identify the causes and risk factors for rehospitalization of inpatients with community-acquired pneumonia. METHODS This project ...
متن کاملCommunity acquired pneumonia: risk factors associated with mortality in a tertiary care hospitalized patients.
OBJECTIVE To evaluate risk factors associated with mortality in patients hospitalized with CommunityAcquired Pneumonia (CAP) from a developing country. METHODS An observational study was conducted on adult patients admitted with a diagnosis of CAP from January 2002 to August 2003 at Aga Khan University hospital, Karachi, Pakistan. Clinical records were reviewed for demographic characteristics...
متن کاملAntibiotics for community-acquired pneumonia.
Antibiotic guidelines for community-acquired pneumonia (CAP) often recommend broad-spectrum agents for severe pneumonia. While these may be entirely appropriate in terms of their spectrum of activity and efficacy, there is a risk that such recommendations could result in over-prescribing of broad-spectrum agents with consequent 'collateral damage', meaning superinfection by resistant pathogens,...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Chest
سال: 2021
ISSN: ['0012-3692', '1931-3543']
DOI: https://doi.org/10.1016/j.chest.2020.06.079